ArticleBMC ophthalmology2026
Extensive recurrent pterygium following photorefractive keratectomy: a case report.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo report an extensive recurrent pterygium following photorefractive keratectomy. CASE PRESENTATION: A healthy 39-year-old male presented with an extensive recurrent pterygium three months after uneventful photorefractive keratectomy. The patient had undergone primary pterygium surgery two months earlier. On presentation, his best-corrected visual acuity was 20/60, and the recurrent pterygium extended across the visual axis. Surgical management included pterygium excision, application of mitomycin C, and free conjunctival autografting. At six-month's postoperative follow-up, uncorrected visual acuity and best-corrected visual acuity improved to 20/32 and 20/25, respectively, with a manifest refraction of +3.25 - 3.5*90. A mild corneal sub-epithelial haziness was observed in the right eye, but no pterygium recurrence was noted. At 33 months postoperative visit, best-corrected visual acuity improved to 20/20 with manifest refraction of Plano - 1.5*110. There was no sign of pterygium recurrence.
conclusionsThe excimer laser, operating within the ultraviolet spectrum, combined with the inflammatory cascade triggered by photorefractive keratectomy, may contribute to pterygium recurrence. In patients with pterygium who are candidates for keratorefractive surgery, selecting a surgical technique with the lowest recurrence rate and ensuring an adequate follow-up period-at least six months-to allow for refractive stabilization and confirm the absence of recurrence is crucial before proceeding with corneal refractive surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.